Positive Earnings and Guidance But Leverage Concerns Persist

What happened

Constellium reported an earnings beat and twice raised FY2026 guidance to $980M–$1.02B Adjusted EBITDA and $300M+ free cash flow, underscoring improved operational momentum. The stock trades at 7.4x trailing earnings and 5.4x EV/EBITDA, the lowest multiples in its peer group, which has attracted value-oriented attention. However, the company still carries high leverage with net debt/EBITDA of 3.3x and interest coverage of only 0.23x, leaving limited margin for error in a cyclical business. The share price has already rallied ~58% over the past year, meaning much of the recovery is priced in, and free cash flow remains volatile and thin relative to revenue. While the raised guidance is encouraging, it does not yet offset the balance sheet fragility that underpins a cautious stance.

Implication

The short-term momentum may persist, but the balance sheet fragility means any cyclical downturn could pressure equity, especially with interest coverage at 0.23x. Sustained positive free cash flow and deleveraging are necessary to confirm durability, as 2024 FCF was negative and recent improvements partly reflect metal price lag. Current multiples are near cyclical norms, so upside from re-rating is limited; returns must come from earnings growth and debt reduction. Monitor the quality of earnings excluding metal price lag and the trajectory of net debt/EBITDA below 3x. Until there is clearer evidence of structural improvement in cash generation, a wait-and-see approach remains prudent.

Thesis delta

The master report's WAIT judgment remains unchanged. The positive earnings and raised guidance are consistent with a cyclical recovery but do not address the core concerns of high leverage and thin free cash flow. The stock's low multiples are offset by the balance sheet risk, and the recent rally has already discounted much of the improvement.